Clinical Trial

Assessment of Cardiorespiratory Fitness in Spondylarthritis

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Spondyloarthritis is a chronic inflammatory joint disease that affects the spine and sacroiliac joints. Most untreated patients eventually experience impaired mobility of the spine, pain and reduced physical function. Exercise is a cornerstone in the treatment of patients with spondylarthritis and it has been shown that high intensity exercise is just as effective in reducing disease activity as immunosuppressive medication. Additionally, patients with spondylarthritis have increased risk of cardiovascular disease both due to traditionally risk factors (obesity, high blood pressure etc) but also due to chronic inflammation. A maximal cardiopulmonary exercise test (CPET) is a measure of cardiorespiratory fitness that can be used to show progression of the exercise and which also is correlated to all-cause mortality and life expectancy. The investigators will validate an indirect maximal CPET against the gold standard with direct gas exchange measurements in patients with spondylarthritis. The indirect test is less time consuming, requires less sophisticated equipment, has lesser requirements to test personnel and facilities, and has less expenditures than the direct test. With a validated indirect maximal CPET the test of cardiorespiratory fitness will be more accessible for patients with spondylarthritis both in-hospital but also municipal.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-21; most recent amendment 2024-08-06.
Status change: Recruiting → Active, Not Recruiting 2024-08-06
Status change: Not Yet Recruiting → Recruiting 2023-10-17
Trial Details
NCT Number NCT05926453
Lead Sponsor Diakonhjemmet Hospital
Conditions Spondylarthritis
Enrollment 55 participants
Start Date 2023-10-17
Primary Completion 2024-07-09 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-07